3D'Souza SP,Davis M, Baxter GF. Autocrine and paracrine actionsof natriuretic peptides in the heart [J]. Pharmacol Ther,2004,101(2):113-129.
4Pemberton CJ,Johnson ML,Yandle TG,ei al. Deconvolution analy-sis of cardiac natriuretic peptides during acute volume overload[J]. Hypertension,2000,36(3) :355-359.
5Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brainnatriuretic polypeptide in patients with atrial fibrillation[ J] . J CardFail,2000,6(2) :92-96.
6Tuinenburg AE,Brundel BJ,Van Gelder lC,et al. Gene expressionof the natriuretic peptide system in atrial tissue of patients with par-oxysmal and persistent atrial fibrillation[ J]. J Cardiovasc Electro-physiol, 1999,10(6) :827-835.
7Luchner A,Stevens TL, Borgeson DD,ei al. Differential atrial andventricular expression of myocardial BNP during evolution of heartfailure[J]. Am J Physiol, 1998,274(5 Pt 2) :H1684-H1689.
8Therkelsen SK,Groenning BA,Kjaer Ayet al. ANP and BNP in at-rial fibrillation before and after cardioversion-and their relationshipto cardiac volume and function [ J ]. Int J Cardiol,2008,127 (3 ):396-399.
9Engelmann MD,Niemann L,Kanstrup YL,et al. Natriuretic peptideresponse to dynamic exercise in patients with atrial fibrillation [ J ].Int J Cardiol,2005,105(1) :31-39.
10Wozakowska-Kaplon B,Opolski G. Exercise-induced natriureticpeptide secretion predicts cardioversion outcome in patients withpersistent atrial fibrillation : discordant ANP and B-type natriureticpeptide response to exercise testing[ J]. Pacing Clin Electrophysi-ol,2010,33( 10) : 1203-1209.
